Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Ebiomedicine|July 17, 2025
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222)Sandra Belij-Rammerstorfer, Emma Sheehan, Grace Li, et al.Wellcome Open Research|December 14, 2022
Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test dataJohn Ojal, Samuel P C Brand, Vincent Were, et al.BMC Infectious Diseases|December 28, 2024
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in KenyaDoreen Lugano, Bernadette Kutima, Makobu Kimani, et al.Wellcome Open Research|August 25, 2025
Comparative performance of the InBios SCoV-2 Detect TM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populationsBernadette Kutima, Eunice Wageci Kagucia, Kennedy Mwai, et al.Nature Communications|June 26, 2021
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in KenyaIfedayo M O Adetifa, Sophie Uyoga, John N Gitonga, et al.Science (New York, N.Y.)|October 7, 2021
COVID-19 transmission dynamics underlying epidemic waves in KenyaSamuel P C Brand, John Ojal, Rabia Aziza, et al.PLOS Global Public Health|March 24, 2023
SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021Anthony O Etyang, Ifedayo Adetifa, Richard Omore, et al.The New England Journal of Medicine|February 19, 2025
Low-Dose Yellow Fever Vaccine in Adults in AfricaDerick Kimathi, Aitana Juan-Giner, Ndeye S Bob, et al.Influenza and Other Respiratory Viruses|September 26, 2023
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022E Wangeci Kagucia, Abdhala K Ziraba, James Nyagwange, et al.Science (New York, N.Y.)|November 12, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donorsSophie Uyoga, Ifedayo M O Adetifa, Henry K Karanja, et al.Pageof 7